TREA

86689495 - PROFERO

Follow

Information

  • Trademark
  • 86689495
  • Serial Number
    86689495
  • Filing Date
    July 10, 2015
    9 years ago
  • Transaction Date
    March 20, 2017
    7 years ago
  • Status Date
    March 20, 2017
    7 years ago
  • Published for Opposition Date
    June 21, 2016
    8 years ago
  • Location Date
    August 16, 2016
    8 years ago
Information
Mark Drawing Code
4000
Mark Identification
PROFERO
Case File Statements
  • GS0011: Chemical test kits for genetic testing for laboratory or research use; Assays and reagents for use in genetic research; Diagnostic preparations for scientific or research use; Nucleic acid isolation and purification kit consisting primarily of reagents for scientific research purposes; Reagents for scientific or medical research use; Clinical diagnostic preparations for medical use
  • GS0051: Testing kits comprised of medical diagnostic reagents and assays that test for the presence of certain genetic properties; Diagnostic agents, preparations and substances for medical purposes; Medical diagnostic reagents for the analysis of genetic material; Preparations for detecting changes in genes and gene expressions for medical purposes; Chemical reagents for medical analysis; Chemical preparation for use in medical analysis, particularly DNA analysis; Pharmaceutical preparations for diagnosis and for identifying and characterizing genetic abnormalities, tracking the progress of disease and measuring the effectiveness of therapies; Genetic identity tests comprises of reagents for medical purposes
  • GS0421: Laboratory diagnostic services in the field of molecular science, comparative genome analysis, nucleic acid arrays and screening of nucleic acids; Medical and scientific research in the field of genetic testing and diagnosis and treatment of medical conditions; Development and laboratory testing in the field of genetics and human disease; Scientific research consulting in the field of genetics, genomics, nucleic acid sequencing, and bioinformatics; Consulting services in the field of pharmaceutical research and development and laboratory testing; Genetic research, development and testing services; Genomic research, development and testing services for scientific research purposes; Nucleic acid collection, testing and analysis services for scientific research purposes; Genetic testing for scientific diagnostic research purposes; Genomic testing for scientific diagnostic research purposes; Medical and scientific research, development and consulting in the field of neurology; Medical and scientific research in the field of genetics and genetic engineering; Medical and scientific research and consulting in the fields of genomics and generation sequencing; Medical and scientific research in the field of disease treatment and diagnosis; Medical and scientific research relating to the design and development of treatment therapies; Data collection for research purposes, namely, the collection, testing and research of patient molecular and/or genomic data; Scientific clinical studies, namely, conducting clinical trials for others; Retrieval and correlation of genomic data; Conducting clinical and pre-clinical trials; Targeted pharmaceutical drug development services; Genotyping; Gene screening; Gene isolation and gene expression analysis for scientific and medical research purposes; Gene mapping; Gene analysis and biomarker discovery for scientific research and medical purposes; Research and development of identification and treatment methods for hereditary factors leading to disease; Nucleic acid-sequencing for scientific research purposes
  • GS0441: Medical diagnostic services in the field of molecular science, comparative genome analysis, nucleic acid arrays and screening of nucleic acids; Medical testing, analysis, and evaluation services for medical or diagnostic purposes for providing healthcare information; Providing health care information featuring information resulting from genomic research, testing, analysis, and evaluation; Diagnosis and treatment of medical conditions, namely, of cognitive, neurological, and brain-related conditions; Providing healthcare information; Providing information in the field of disease prevention, screening, diagnosis, and treatment for medical diagnostic and treatment purposes; Medical testing services for diagnostic or treatment purposes in the medical field; Proteogenomic profiling for diagnostic or treatment purposes of cognitive, neurological, and brain-related conditions; Identification of target molecules for disease treatment, namely, treatments of cognitive, neurological, and brain-related conditions
Case File Event Statements
  • 3/20/2017 - 7 years ago
    23 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Type: MAB6
  • 3/20/2017 - 7 years ago
    22 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 8/16/2016 - 8 years ago
    21 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 6/21/2016 - 8 years ago
    20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/21/2016 - 8 years ago
    19 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/1/2016 - 8 years ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/16/2016 - 8 years ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/16/2016 - 8 years ago
    16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 5/16/2016 - 8 years ago
    15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 5/16/2016 - 8 years ago
    14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 5/16/2016 - 8 years ago
    13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 5/12/2016 - 8 years ago
    12 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX
  • 4/26/2016 - 8 years ago
    11 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR
  • 4/8/2016 - 8 years ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/30/2016 - 8 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/30/2016 - 8 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/30/2016 - 8 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/2/2015 - 9 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 10/2/2015 - 9 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 10/2/2015 - 9 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/24/2015 - 9 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/15/2015 - 9 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 7/14/2015 - 9 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP